Compare NVST & WD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVST | WD |
|---|---|---|
| Founded | 2018 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.8B |
| IPO Year | 2019 | 2010 |
| Metric | NVST | WD |
|---|---|---|
| Price | $21.81 | $62.77 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 2 |
| Target Price | $21.09 | ★ $96.00 |
| AVG Volume (30 Days) | ★ 2.0M | 273.0K |
| Earning Date | 10-29-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 4.28% |
| EPS Growth | N/A | ★ 20.18 |
| EPS | 0.09 | ★ 3.37 |
| Revenue | ★ $2,621,800,000.00 | $1,160,070,000.00 |
| Revenue This Year | $7.42 | $19.30 |
| Revenue Next Year | $3.63 | $10.04 |
| P/E Ratio | $253.17 | ★ $18.59 |
| Revenue Growth | 4.73 | ★ 17.65 |
| 52 Week Low | $14.22 | $60.72 |
| 52 Week High | $22.68 | $108.58 |
| Indicator | NVST | WD |
|---|---|---|
| Relative Strength Index (RSI) | 64.44 | 36.14 |
| Support Level | $19.89 | $61.50 |
| Resistance Level | $22.48 | $64.62 |
| Average True Range (ATR) | 0.62 | 1.82 |
| MACD | 0.20 | 0.64 |
| Stochastic Oscillator | 77.94 | 41.95 |
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling, and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company is managed based on three reportable segments: Capital Markets (CM), Servicing & Asset Management (SAM), and Corporate. The company generates a majority of total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.